Cargando…

Exercise related ventricular arrhythmias are related to cardiac fibrosis in hypertrophic cardiomyopathy mutation carriers

AIMS: Hypertrophic cardiomyopathy (HCM) is a frequent cause of sudden cardiac death (SCD) due to exercise-related ventricular arrhythmias (ERVA); however the pathological substrate is uncertain. The aim was to determine the prevalence of ERVA and their relation with fibrosis as determined by cardiac...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Rijsingen, I. A. W., Bekkers, S. C. A. M., Schalla, S., Hermans-van Ast, J. F., Snoep, G., Alzand, B. S. N., Arens, Y. H. J. M., van den Wijngaard, A., Crijns, H. J. G. M., Pinto, Y. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058538/ https://www.ncbi.nlm.nih.gov/pubmed/21475680 http://dx.doi.org/10.1007/s12471-011-0090-8

Ejemplares similares

Detection and characteristics of microvascular obstruction in reperfused acute myocardial infarction using an optimized protocol for contrast-enhanced cardiovascular magnetic resonance imaging
por: Bekkers, Sebastiaan C. A. M., et al.
Publicado: (2009)

Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy
por: Haland, Trine F., et al.
Publicado: (2016)

Unrecognized myocardial infarction by echocardiography in relation to infarct characteristics as assessed by cardiovascular magnetic resonance imaging
por: Jaarsma, Caroline, et al.
Publicado: (2012)

Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study
por: Hermans, Mieke CE, et al.
Publicado: (2012)

Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy
por: van den Wijngaard, A., et al.
Publicado: (2011)

Determining the optimal interval for imaging surveillance of ascending aortic aneurysms
por: Adriaans, B. P., et al.
Publicado: (2021)

Magnetic resonance imaging of the coronary arteries
por: Gerretsen, SC, et al.
Publicado: (2007)

BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status
por: Jansen, M., et al.
Publicado: (2021)

Comparison of different electrocardiographic criteria for the detection of previous myocardial infarction in relation to infarct characteristics as assessed with cardiovascular magnetic resonance imaging
por: Jaarsma, Caroline, et al.
Publicado: (2013)

Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy
por: Du, Darson, et al.
Publicado: (2022)

Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants
por: Jansen, Mark, et al.
Publicado: (2023)

The year in cardiovascular medicine 2021: arrhythmias
por: Crijns, Harry J.G.M., et al.
Publicado: (2022)

Right ventricular function in dilated cardiomyopathy and ischemic heart disease: assessment with non-invasive imaging
por: Schalla, S., et al.
Publicado: (2015)

Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias
por: Ariga, Rina, et al.
Publicado: (2019)

Five-year prognostic significance of global longitudinal strain in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes
por: van Velzen, H. G., et al.
Publicado: (2019)

Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers–reaching the frontiers of individual risk prediction
por: Verstraelen, Tom E, et al.
Publicado: (2021)

Myocardial Structural Alteration and Systolic Dysfunction in Preclinical Hypertrophic Cardiomyopathy Mutation Carriers
por: Yiu, Kai Hang, et al.
Publicado: (2012)

Clinical assessment of aortic valve stenosis: Comparison between 4D flow MRI and transthoracic echocardiography
por: Adriaans, Bouke P., et al.
Publicado: (2019)

Diagnostic performance of PET, SPECT and CMR perfusion imaging for the detection of significant coronary artery disease - a meta-analysis
por: Jaarsma, Caroline, et al.
Publicado: (2011)

Scar architecture determinants of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study
por: Francia, P, et al.
Publicado: (2023)

Prognostic significance of left atrial strain in sarcomere gene variant carriers without hypertrophic cardiomyopathy
por: Huurman, Roy, et al.
Publicado: (2022)

Epidemiology of gender-related differences of arrhythmias in the ICU
por: Priglinger, U, et al.
Publicado: (2001)

Hypertrophic cardiomyopathy with little hypertrophy and severe arrhythmia
por: Ripoll-Vera, Tomas, et al.
Publicado: (2018)

Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers
por: Parbhudayal, Rahana Y., et al.
Publicado: (2021)

Concentric hypertrophic remodelling and subendocardial dysfunction in mitochondrial DNA point mutation carriers(†)
por: Bates, Matthew G.D., et al.
Publicado: (2013)

International Practice Patterns in the Detection and Management of Arrhythmias in Patients With Hypertrophic Cardiomyopathy
por: Cheung, Matthew, et al.
Publicado: (2022)

MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset
por: Marsili, Luisa, et al.
Publicado: (2023)

QT prolongation-related ventricular arrhythmia associated with atrial fibrillation electrical cardioversion
por: Rav Acha, M, et al.
Publicado: (2023)

Hypertrophic neuropathy: a possible cause of pain in children with Noonan syndrome and related disorders
por: Draaisma, Fieke, et al.
Publicado: (2023)

Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness
por: Rüssel, Iris K, et al.
Publicado: (2011)

Number of comorbidities is associated with symptom severity and arrhythmia progression in paroxysmal atrial fibrillation - Data from the RACE V study
por: Van De Lande, M E, et al.
Publicado: (2023)

Cardiovascular magnetic resonance accurately detects obstructive coronary artery disease in suspected non-ST elevation myocardial infarction: a sub-analysis of the CARMENTA Trial
por: van Cauteren, Yvonne J. M., et al.
Publicado: (2021)

Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers
por: Lorenzini, Massimiliano, et al.
Publicado: (2020)

Incremental value of cardiovascular magnetic resonance over echocardiography in the detection of acute and chronic myocardial infarction
por: Jaarsma, Caroline, et al.
Publicado: (2013)

Risks of Ventricular Arrhythmia and Heart Failure in Carriers of RBM20 Variants
por: Cannie, Douglas E., et al.
Publicado: (2023)

OP4-4 Prevalence, quantification and cut-off level of parvovirus B19 DNA in endomyocardial biopsies of cardiac patients and non-cardiac control subjects
por: Goossens, V.J., et al.
Publicado: (2009)

Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines
por: Lu, H R, et al.
Publicado: (2008)

How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance
por: Germans, Tjeerd, et al.
Publicado: (2010)

Haemodynamic bradycardia in tachycardiomyopathy
por: Mafirad, M., et al.
Publicado: (2011)

Focal myocardial fibrosis detected with magnetic resonance late Gadolinium enhancement imaging and diffuse interstitial fibrosis determined with histological staining of endomyocardial biopsy specimens in patients with non-ischemic left ventricular systolic dysfunction: two distinct entities?
por: Schalla, Simon, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_32da45orgbceblo5co1tkauihu